文献速递乳腺癌放疗放疗物理与技术姑息放疗与转移瘤

COVID-19疫情初期放疗科重组:单中心经验与对放疗实践的影响

Radiation Therapy Department Reorganization during the Coronavirus Disease 2019 (COVID-19) Outbreak: Keys to Securing Staff and Patients During the First Weeks of the Crisis and Impact on Radiation Therapy Practice from a Single Institution Experience.
PubMed 文献 · Adv Radiat Oncol · 2020-05-27

法国单中心报告COVID-19疫情最初数周内放疗科为降低员工和患者风险而采取的组织重组措施。研究回顾了全科患者的放疗分割方案,目标为减少每日来院放疗患者数、调整人力资源并支援COVID-19病区。共识别50例患者,多数为女性(64%)乳腺癌(54%),44%患者放疗延迟,42%患者考虑大分割放疗,原计划疗程数从1383减少至683(减少50%)。

要点

  • 通过调整分割方案和延迟放疗,将计划疗程数从1383减至683,减少50%。
  • 44%患者放疗延迟,多数以激素治疗作为等待期治疗。
  • 42%患者考虑大分割放疗,其中86%为乳腺癌患者。

核心结论

  • 疫情期间通过主动减少接受放疗的患者数量并调整组织架构,成功降低COVID-19传播风险并节约资源。

研究设计与样本

  • 单中心回顾性研究,回顾全科所有正在接受治疗及即将开始治疗患者的放疗分割方案。

主要发现

  • 共识别50例患者,其中6例正在治疗,41例计划CT模拟定位后开始放疗,3例CT扫描待安排。
  • 多数为女性(64%)且为乳腺癌患者(54%)。
  • 22例(44%)患者放疗延迟,多数以激素治疗作为等待期治疗。
  • 21例(42%)患者考虑大分割放疗,其中18例(86%)为乳腺癌。
  • 2020年3月15日至5月31日期间,原计划疗程数为1383,因疫情重新计划后为683,减少50%(包括延迟的疗程)。

临床怎么用

  • 疫情等资源紧张时期可主动减少每日来院放疗患者数,优先采用大分割放疗和延迟策略。
  • 对延迟放疗的乳腺癌患者可考虑激素治疗作为等待期治疗。
  • 调整人力资源以维持科室诊疗并支援医院其他病区。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: During the first weeks of the coronavirus disease 2019 (COVID-19) outbreak in France, it was necessary to clearly define organizational priorities in the radiation therapy (RT) departments. In this report, we focus on the urgent measures taken to reduce risk for both our staff and patients by reducing the number of patients receiving treatment. METHODS AND MATERIALS: We reviewed the fractionation schemes for all patients in our department, including those receiving treatment and those soon to start treatment. Our goals were to (1) decrease the number of patients coming daily to the hospital for RT, (2) adapt our human resources to continue patients' care in the department, and (3) help to cover understaffed COVID-19 sectors of the hospital. RESULTS: We identified 50 patients who were receiving treatment (n = 6), were going to start radiation after CT scan simulation (n = 41), or for whom the CT scan was pending (n = 3). The majority were women (64%) treated for breast cancer (54%). RT was delayed for 22 (44%) patients. The majority were offered hormone therapy as "waiting therapy." Hypofractionation was considered in 21 (42%) patients mainly with breast cancer (18 of 21, 86%). The number of courses initially planned and replanned as a result of the COVID-19 outbreak during the period of March 15 to May 31, 2020, were 1383 and 683, respectively, which represented a reduction of 50% (including delayed sessions) that allowed our reorganization process. CONCLUSIONS: To conserve resources during the pandemic, we successfully reduced the number of patients receiving treatment in a proactive fashion and adapted our organization to minimize the risk of COVID-19 contamination. Departments across the world may benefit from this same approach.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Belkacemi Y, Loaganadane G, Grellier N, et al. Radiation Therapy Department Reorganization during the Coronavirus Disease 2019 (COVID-19) Outbreak: Keys to Securing Staff and Patients During the First Weeks of the Crisis and Impact on Radiation Therapy Practice from a Single Institution Experience. Adv Radiat Oncol. 2020. PMID: 32775775. doi:10.1016/j.adro.2020.04.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。